142 related articles for article (PubMed ID: 37767858)
1. Philippine immunization coverage and dengvaxia: An infodemiological study.
Jamora RDG; Lim MAR; Espiritu AI
Pediatr Int; 2023; 65(1):e15623. PubMed ID: 37767858
[TBL] [Abstract][Full Text] [Related]
2. Implications of information heard about Dengvaxia on Filipinos' perception on vaccination.
Mabale MAA; Tejero LMS; Montes LA; Collante MTM; Tempongko MSB; Tolabing MCC
Vaccine; 2024 Mar; 42(7):1673-1681. PubMed ID: 38350770
[TBL] [Abstract][Full Text] [Related]
3. 'I was terrified for my child': understanding the link between the Dengvaxia® controversy and the measles vaccine hesitancy in Pasay City, Philippines.
Miras AP; Regencia ZJG; Baja ES
J Public Health (Oxf); 2023 Nov; 45(4):912-918. PubMed ID: 37340460
[TBL] [Abstract][Full Text] [Related]
4. A review of Dengvaxia®: development to deployment.
Thomas SJ; Yoon IK
Hum Vaccin Immunother; 2019; 15(10):2295-2314. PubMed ID: 31589551
[TBL] [Abstract][Full Text] [Related]
5. Pre-vaccination screening strategies for the use of the CYD-TDV dengue vaccine: A meeting report.
Wilder-Smith A; Smith PG; Luo R; Kelly-Cirino C; Curry D; Larson H; Durbin A; Chu M; Tharmaphornpilas P; Ng LC; Sartori AMC; Luna EJA; Gubler DJ; España G; Yoon IK; Flasche S
Vaccine; 2019 Aug; 37(36):5137-5146. PubMed ID: 31377079
[TBL] [Abstract][Full Text] [Related]
6. Ethics of a partially effective dengue vaccine: Lessons from the Philippines.
Halstead SB; Katzelnick LC; Russell PK; Markoff L; Aguiar M; Dans LR; Dans AL
Vaccine; 2020 Jul; 38(35):5572-5576. PubMed ID: 32654899
[TBL] [Abstract][Full Text] [Related]
7. The importance of effective risk communication and transparency: lessons from the dengue vaccine controversy in the Philippines.
Dayrit MM; Mendoza RU; Valenzuela SA
J Public Health Policy; 2020 Sep; 41(3):252-267. PubMed ID: 32518285
[TBL] [Abstract][Full Text] [Related]
8. A multi-country study of dengue vaccination strategies with Dengvaxia and a future vaccine candidate in three dengue-endemic countries: Vietnam, Thailand, and Colombia.
Lee JS; Lourenço J; Gupta S; Farlow A
Vaccine; 2018 Apr; 36(17):2346-2355. PubMed ID: 29573874
[TBL] [Abstract][Full Text] [Related]
9. Vaccine confidence plummets in the Philippines following dengue vaccine scare: why it matters to pandemic preparedness.
Larson HJ; Hartigan-Go K; de Figueiredo A
Hum Vaccin Immunother; 2019; 15(3):625-627. PubMed ID: 30309284
[TBL] [Abstract][Full Text] [Related]
10. Identification of prior dengue-naïve Dengvaxia recipients with an increased risk for symptomatic dengue during fever surveillance in the Philippines.
Dai YC; Sy AK; Jiz M; Tsai JJ; Bato J; Quinoñes MA; Reyes MAJ; Wang WK
Front Immunol; 2023; 14():1202055. PubMed ID: 37554332
[TBL] [Abstract][Full Text] [Related]
11. Vaccination coverage and adherence to a dengue vaccination program in the state of Paraná, Brazil.
Preto C; Maron de Mello A; Cesário Pereira Maluf EM; Teixeira Krainski E; Graeff G; de Sousa GA; da Silva LR; Vieira da Costa-Ribeiro MC; da Cruz Magalhães Buffon M; Shimakura SE; Raboni SM; Siqueira de Carvalho D; Luhm KR
Vaccine; 2021 Jan; 39(4):711-719. PubMed ID: 33386178
[TBL] [Abstract][Full Text] [Related]
12. The Long-Term Safety, Public Health Impact, and Cost-Effectiveness of Routine Vaccination with a Recombinant, Live-Attenuated Dengue Vaccine (Dengvaxia): A Model Comparison Study.
Flasche S; Jit M; Rodríguez-Barraquer I; Coudeville L; Recker M; Koelle K; Milne G; Hladish TJ; Perkins TA; Cummings DA; Dorigatti I; Laydon DJ; España G; Kelso J; Longini I; Lourenco J; Pearson CA; Reiner RC; Mier-Y-Terán-Romero L; Vannice K; Ferguson N
PLoS Med; 2016 Nov; 13(11):e1002181. PubMed ID: 27898668
[TBL] [Abstract][Full Text] [Related]
13. Fear, mistrust, and vaccine hesitancy: Narratives of the dengue vaccine controversy in the Philippines.
Yu VG; Lasco G; David CC
Vaccine; 2021 Aug; 39(35):4964-4972. PubMed ID: 34330555
[TBL] [Abstract][Full Text] [Related]
14. Does structurally-mature dengue virion matter in vaccine preparation in post-Dengvaxia era?
Galula JU; Salem GM; Chang GJ; Chao DY
Hum Vaccin Immunother; 2019; 15(10):2328-2336. PubMed ID: 31314657
[TBL] [Abstract][Full Text] [Related]
15. Projected Impact of Dengue Vaccination in Yucatán, Mexico.
Hladish TJ; Pearson CA; Chao DL; Rojas DP; Recchia GL; Gómez-Dantés H; Halloran ME; Pulliam JR; Longini IM
PLoS Negl Trop Dis; 2016 May; 10(5):e0004661. PubMed ID: 27227883
[TBL] [Abstract][Full Text] [Related]
16. Implementing a dengue vaccination programme-who, where and how?
E Clapham H; A Wills B
Trans R Soc Trop Med Hyg; 2018 Aug; 112(8):367-368. PubMed ID: 30016491
[TBL] [Abstract][Full Text] [Related]
17. Dengue Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021.
Paz-Bailey G; Adams L; Wong JM; Poehling KA; Chen WH; McNally V; Atmar RL; Waterman SH
MMWR Recomm Rep; 2021 Dec; 70(6):1-16. PubMed ID: 34978547
[TBL] [Abstract][Full Text] [Related]
18. Dengue Dynamics and Vaccine Cost-Effectiveness Analysis in the Philippines.
Shim E
Am J Trop Med Hyg; 2016 Nov; 95(5):1137-1147. PubMed ID: 27601519
[TBL] [Abstract][Full Text] [Related]
19. Public trust and the COVID-19 vaccination campaign: lessons from the Philippines as it emerges from the Dengvaxia controversy.
Mendoza RU; Dayrit MM; Alfonso CR; Ong MMA
Int J Health Plann Manage; 2021 Nov; 36(6):2048-2055. PubMed ID: 34414601
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of a single-dose mass dengue vaccination in Cebu, Philippines: A case-control study.
Ylade M; Agrupis KA; Daag JV; Crisostomo MV; Tabuco MO; Sy AK; Nealon J; Macina D; Sarol J; Deen J; Lopez AL
Vaccine; 2021 Aug; 39(37):5318-5325. PubMed ID: 34373121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
